|
1
|
Le Rhun E, Weller M, Brandsma D, Van den
Bent M, de Azambuja E, Henriksson R, Boulanger T, Peters S, Watts
C, Wick W, et al: EANO-ESMO clinical practice guidelines for
diagnosis, treatment and follow-up of patients with leptomeningeal
metastasis from solid tumours. Ann Oncol. 28 (Suppl_4):iv84–iv99.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chamberlain M, Junck L, Brandsma D,
Soffietti R, Rudà R, Raizer J, Boogerd W, Taillibert S, Groves MD,
Le Rhun E, et al: Leptomeningeal metastases: A RANO proposal for
response criteria. Neuro Oncol. 19:484–492. 2017.PubMed/NCBI
|
|
3
|
Freilich RJ, Krol G and DeAngelis LM:
Neuroimaging and cerebrospinal fluid cytology in the diagnosis of
leptomeningeal metastasis. Ann Neurol. 38:51–57. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Groves MD: New strategies in the
management of leptomeningeal metastases. Arch Neurol. 67:305–312.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yi HG, Kim HJ, Kim YJ, Han SW, Oh DY, Lee
SH, Kim DW, Im SA, Kim TY, Kim CS, et al: Epidermal growth factor
receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for
leptomeningeal metastasis from non-small cell lung cancer patients
with sensitive EGFR mutation or other predictive factors of good
response for EGFR TKI. Lung Cancer. 65:80–84. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brastianos PK, Lee EQ, Cohen JV, Tolaney
SM, Lin NU, Wang N, Chukwueke U, White MD, Nayyar N, Kim A, et al:
Single-arm, open-label phase 2 trial of pembrolizumab in patients
with leptomeningeal carcinomatosis. Nat Med. 26:1280–1284. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gwak HS and Lee SH, Park WS, Shin SH, Yoo
H and Lee SH: Recent advancements of treatment for leptomeningeal
carcinomatosis. J Korean Neurosurg Soc. 58:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nakagawa H, Fujita T, Kubo S, Izumoto S,
Nakajima Y, Tsuruzono K, Tokiyoshi K and Hayakawa T:
Ventriculolumbar perfusion chemotherapy with methotrexate and
cytosine arabinoside for meningeal carcinomatosis: A pilot study in
13 patients. Surg Neurol. 45:256–264. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gwak HS, Lim HS, Shin SH, Yoo H, Han JY,
Kim HT, Yun T, Lee JS and Lee SH: Ventriculolumbar perfusion
chemotherapy for the treatment of leptomeningeal carcinomatosis: A
phase I study with pharmacokinetic data. Am J Clin Oncol.
36:491–499. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gwak HS, Joo J, Shin SH, Yoo H, Han JY,
Kim HT, Yun T, Ro J, Lee JS and Lee SH: Ventriculolumbar perfusion
chemotherapy with methotrexate for treating leptomeningeal
carcinomatosis: A phase II study. Oncologist. 19:1044–1045. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gauthier H, Guilhaume MN, Bidard FC,
Pierga JY, Girre V, Cottu PH, Laurence V, Livartowski A, Mignot L
and Diéras V: Survival of breast cancer patients with meningeal
carcinomatosis. Ann Oncol. 21:2183–2187. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hyun JW, Park JH, Kang BG, Park EY, Park
B, Joo J, Kim JK, Kim SH, Jeong JH, Lee HW, et al: Diagnostic and
prognostic values of cerebrospinal fluid CYFRA 21-1 in patients
with leptomeningeal carcinomatosis. Oncotarget. 8:53326–53335.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Khalil M, Teunissen CE, Otto M, Piehl F,
Sormani MP, Gattringer T, Barro C, Kappos L, Comabella M, Fazekas
F, et al: Neurofilaments as biomarkers in neurological disorders.
Nat Rev Neurol. 14:577–589. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Choi YH, Gwak HS, Joo J, Kwon JW, Shin SH,
Yoo H, Lee JH and Youn JH: Efficacy of slow rate ventriculolumbar
perfusion chemotherapy for leptomeningeal carcinomatosis: Interim
result of a phase II study. Brain Tumor Res Treat. 7:85–91. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Khalil M, Pirpamer L, Hofer E, Voortman
MM, Barro C, Leppert D, Benkert P, Ropele S, Enzinger C, Fazekas F,
et al: Serum neurofilament light levels in normal aging and their
association with morphologic brain changes. Nat Commun. 11:8122020.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Contal C and O'Quigley J: An application
of change point methods in studying the effect of age on survival
in breast cancer. Comp Stat Data Anal. 30:253–270. 1999. View Article : Google Scholar
|
|
17
|
Ko Y, Gwak HS, Park EY, Joo J, Lee YJ, Lee
SH, Kwon JW, Shin SH and Yoo H: Association of MRI findings with
clinical characteristics and prognosis in patients with
leptomeningeal carcinomatosis from non-small cell lung cancer. J
Neurooncol. 143:553–562. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chamberlain MC: Radioisotope CSF flow
studies in leptomeningeal metastases. J Neurooncol. 38:135–140.
1998. View Article : Google Scholar : PubMed/NCBI
|
